Maximising opportunities for integrated care: MDTs and COPD care
18 Nov 2024
About the event
AstraZeneca’s Transforming COPD care webinar series aims to highlight the current challenges associated with COPD management and how these could be addressed by optimising maintenance therapy and interventions to reduce exacerbations. This webinar will focus on how to improve COPD care pathways for COPD and how to better implement integrated ways of working for multidisciplinary teams. It will highlight the potential clinical role of TRIXEO for COPD disease management in uncontrolled patients on dual therapy.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
